Michael Dziegelewski
机构：Boehringer Ingelheim (United States)
发表论文 4 篇 · 总被引 126 次 · h-index 2
代表论文
- Production of Monoclonal Antibodies (2013 · Current Protocols in Immunology · 被引 113)
- An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases (2021 · International Journal of Pharmaceutics · 被引 11)
- Determination of the SLAMF1 self-association affinity constant with sedimentation velocity ultracentrifugation (2021 · Analytical Biochemistry · 被引 2)
- Characterization of novel CD25 antibodies that deplete human regulatory T cells in humanized mouse model (2020 · The Journal of Immunology)